Pulmonx Corp

LUNG NASDAQ Santé & Biotech États-Unis US7458481014
1.34 $
0.75 %

Pulmonx Corp propose des dispositifs médicaux et des dédiées au traitement de maladies pulmonaires, notamment l'emphysème.

Performance & Momentum

6 Months 35.05 %
1 Year 62.61 %
3 Years 89.98 %
5 Years 96.65 %

Similar stocks to Pulmonx Corp

Anantys Community

Be the first to share your analysis on Pulmonx Corp.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases